Review summary
Teaching objective: A neurocognitive disorder after repetitive head impacts and a later assault, with chronic PTSD, in a 67-year-old retired world champion boxer who comes with his care partner because of memory loss and confusion. The episode follows the 2024 Alzheimer's Association DETeCD-ADRD guideline (history from him and an informant, the MoCA and CDR, function, reversible causes, a medicine review, brain MRI and neuropsychological testing, disclosure and counseling) and shows how the NINDS 2021 criteria for traumatic encephalopathy syndrome are research criteria, not a clinical diagnosis; how PTSD, depression and moral injury (guilt and self-blame after a fight in which his opponent died) are screened and treated under the VA/DoD 2023 PTSD guideline, with cognitive processing therapy adapted for memory problems, sertraline with sodium checks, and a structured safety assessment with the 988 Suicide & Crisis Lifeline; why no cholinesterase inhibitor is used for mild cognitive impairment; falls; caregiver support; and advance care planning while he can take part fully. It respects the way he described his own life and sexuality, and makes no claim about his private health beyond the public record.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| February 3, 1938 | Born in St. Thomas, U.S. Virgin Islands. | CLM-0001 |
| 1958 | Turns professional in New York. | CLM-0002 |
| March 24, 1962 | Regains the welterweight title; his opponent dies ten days later; the fight stays with him for life. | CLM-0004, CLM-0005 |
| 1977 | Retires after 112 professional bouts over nineteen years. | CLM-0003, CLM-0010 |
| 1992 | Badly beaten by a group of men after leaving a bar near Times Square; months in hospital. | CLM-0008 |
| April 2005 | A documentary about his life is released; a review reports short-term memory problems since the attack. | CLM-0005, CLM-0007, CLM-0009 |
| His final years | Pugilistic dementia, with full-time care, in a nursing home in Hempstead, New York. | CLM-0011 |
| July 23, 2013 | Dies at 75 at an extended care facility in Hempstead. | CLM-0012 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Emile Alphonse Griffith was born on February 3, 1938, in St. Thomas, U.S. Virgin Islands, one of eight children. History only. The sources read give St. Thomas; none names the town. |
confirmed | Malvasi MG. Griffith, Emile Alphonse. Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures supports Fanfair R. Emile Griffith was a trailblazer for USVI athletes supports HISTMED Master Roster v3 context |
| D | He moved to New York City as a young man and turned professional in 1958. History only. |
confirmed | Malvasi MG. Griffith, Emile Alphonse. Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures supports |
| D | He boxed professionally for nineteen years, from 1958 to 1977, in 112 bouts (a record of 85 wins, 24 losses and 2 draws), won five world titles at welterweight and middleweight, was the first boxer from the U.S. Virgin Islands to become a world champion, and retired at 39, after losing his last three fights; he entered the International Boxing Hall of Fame in 1990. Anchors the long exposure to repetitive head impacts in the modern episode. |
confirmed | Malvasi MG. Griffith, Emile Alphonse. Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures supports Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports HISTMED Master Roster v3 context |
| D | On March 24, 1962, at Madison Square Garden, he regained the welterweight title by stopping Benny Paret in the twelfth round; Paret never regained consciousness, had emergency brain surgery, and died ten days later. Sports Illustrated reported in 2005 that an anti-gay slur Paret directed at him at the weigh-in may have fueled him. Documented history; the opponent is named only here. Anchors the trauma history in the modern episode. |
confirmed | Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports Malvasi MG. Griffith, Emile Alphonse. Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures supports |
| D | The fight's outcome stayed with him for decades. His biographer said he saw visions of Paret at night and in a mirror and refused to box again for months; Griffith said he was "never the same fighter after that"; and in a documentary released in 2005 he told Paret's son, "Sometimes I still have nightmares." His own public words and his biographer's public account. Anchors the nightmares and intrusive memories in the modern episode. |
confirmed | Opponent Who Died After Fight Weighed Heavily On Boxer Emile Griffith. NPR, July 26, 2013 (via WFAE) supports Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports King Kaufman's Sports Daily: Emile Griffith and USA Network's Ring of Fire. Salon, April 20, 2005 supports |
| R | The project roster describes post-traumatic stress disorder from the ring death. No source read records that diagnosis; the documented nightmares, visions and lasting distress are consistent with it only as a retrospective interpretation. Retrospective interpretation, not a historical diagnosis. The modern episode diagnoses PTSD synthetically, anchored to his own public words. |
possible | HISTMED Master Roster v3 supports Opponent Who Died After Fight Weighed Heavily On Boxer Emile Griffith. NPR, July 26, 2013 (via WFAE) supports King Kaufman's Sports Daily: Emile Griffith and USA Network's Ring of Fire. Salon, April 20, 2005 supports |
| D | Over the years he described himself at various times as straight, gay and bisexual; in a 2005 interview with Sports Illustrated he said, "I don't know what I am." His biographer said he lived openly, going to gay bars, but did not say so publicly until after the 2005 documentary about him. Social history in his own public words, recorded with respect; not a medical matter. |
confirmed | Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports Former world champ Emile Griffith dead. Australian Associated Press, July 24, 2013 (via SBS News) supports Opponent Who Died After Fight Weighed Heavily On Boxer Emile Griffith. NPR, July 26, 2013 (via WFAE) supports |
| D | In 1992 he was attacked and badly beaten by a group of men, one with a baseball bat, after leaving a gay bar in midtown Manhattan near Times Square; he spent several months in hospital, much of it in intensive care. The motive was never established. Anchors the severe traumatic brain injury and the second traumatic event in the modern episode. The sources differ on details (four months in hospital; several months in intensive care); the record keeps what they share. |
confirmed | Malvasi MG. Griffith, Emile Alphonse. Scribner Encyclopedia of American Lives, Thematic Series: Sports Figures supports Former world champ Emile Griffith dead. Australian Associated Press, July 24, 2013 (via SBS News) supports Vanderborg C. Emile Griffith dead: boxer known for fatal Benny Paret match dies at age 75. International Business Times, July 24, 2013 supports Fanfair R. Emile Griffith was a trailblazer for USVI athletes supports |
| D | A 2005 review of the documentary reported that he had had short-term memory problems since the 1992 attack. A press report, not a medical record. Anchors the presenting memory problem and the index year. |
probable | King Kaufman's Sports Daily: Emile Griffith and USA Network's Ring of Fire. Salon, April 20, 2005 supports |
| D | After boxing he trained other boxers, including world champions, and worked as a corrections officer and a bartender. Anchors his strengths and work history. |
confirmed | Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports Fanfair R. Emile Griffith was a trailblazer for USVI athletes supports |
| D | Late in life he had pugilistic dementia and needed full-time care; he lived in a nursing home in Hempstead, New York. History after the modern episode; not used in intake documents. |
confirmed | Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports Fanfair R. Emile Griffith was a trailblazer for USVI athletes supports Vanderborg C. Emile Griffith dead: boxer known for fatal Benny Paret match dies at age 75. International Business Times, July 24, 2013 supports |
| D | He died on July 23, 2013, at 75, at an extended care facility in Hempstead, New York; his biographer said kidney failure and complications of dementia caused his death. Recorded once, in plain words. |
confirmed | Former boxing champion Emile Griffith dies at 75. Associated Press, July 23, 2013 (via Fox News) supports Vanderborg C. Emile Griffith dead: boxer known for fatal Benny Paret match dies at age 75. International Business Times, July 24, 2013 supports Fanfair R. Emile Griffith was a trailblazer for USVI athletes supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be found | resolved | confirmed | active | CLM-0009 |
| S | Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41 | active | confirmed | both_with_link | CLM-0005, CLM-0006, CLM-0008 |
| S | Mild cognitive impairment (mild neurocognitive disorder) with slowed processing, executive and memory-retrieval deficits, most likely due to traumatic brain injury from a nineteen-year professional boxing career and a severe assault; meets the NINDS research criteria for traumatic encephalopathy syndrome (a research diagnosis); Alzheimer's disease co-pathology not excluded | active | confirmed | both_with_link | CLM-0009, CLM-0003, CLM-0008 |
| S | Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospital | active | confirmed | active | CLM-0003, CLM-0008 |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-05-05 | Leukocytes [#/volume] in Blood by Automated count | 6.1 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-05-05 | Hemoglobin [Mass/volume] in Blood | 14.2 g/dL Reference 13.5-17.5 g/dL |
http://loinc.org · 718-7 |
| S | 2026-05-05 | Platelets [#/volume] in Blood by Automated count | 228 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-05-05 | Sodium [Moles/volume] in Serum or Plasma | 140 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-05-05 | Potassium [Moles/volume] in Serum or Plasma | 4.2 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-05-05 | Creatinine [Mass/volume] in Serum or Plasma | 1 mg/dL Reference 0.74-1.35 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-05-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 82 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-05-05 | Glucose [Mass/volume] in Serum or Plasma | 94 mg/dL Reference 70-140 mg/dL |
http://loinc.org · 2345-7 |
| S | 2026-05-05 | Calcium [Mass/volume] in Serum or Plasma | 9.4 mg/dL Reference 8.6-10.3 mg/dL |
http://loinc.org · 17861-6 |
| S | 2026-05-05 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 418 pg/mL Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 2026-05-05 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-05-05 | Total score [MoCA] | 22 | http://loinc.org · 72172-0 |
| S | 2026-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | http://loinc.org · 44261-6 |
| S | 2026-05-05 | PC-PTSD-5 score [PC-PTSD-5] | 4 | http://loinc.org · 102017-1 |
| S | 2026-05-05 | PTSD PCL-5 score [PCL-5] | 41 | http://loinc.org · 101698-9 |
| S | 2026-05-19 | Sodium [Moles/volume] in Serum or Plasma | 138 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-05-19 | Clinical Dementia Rating scale [CDR] | 0.5 | http://loinc.org · 72088-8 |
| S | 2026-06-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | http://loinc.org · 44261-6 |
| S | 2026-06-16 | PTSD PCL-5 score [PCL-5] | 37 | http://loinc.org · 101698-9 |
| S | 2026-09-15 | Sodium [Moles/volume] in Serum or Plasma | 137 mmol/L Reference 135-145 mmol/L |
http://loinc.org · 2951-2 |
| S | 2026-09-15 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | http://loinc.org · 44261-6 |
| S | 2026-09-15 | PTSD PCL-5 score [PCL-5] | 26 | http://loinc.org · 101698-9 |
| S | 2026-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | http://loinc.org · 44261-6 |
| S | 2026-10-27 | PTSD PCL-5 score [PCL-5] | 20 | http://loinc.org · 101698-9 |
| S | 2026-08-04 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 6 | http://loinc.org · 44261-6 |
| S | 2026-08-04 | Total score [AUDIT-C] | 2 | http://loinc.org · 75626-2 |
| S | 2026-08-04 | Cholesterol [Mass/volume] in Serum or Plasma | 186 mg/dL Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-08-04 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 mg/dL Reference >=40 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-08-04 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 mg/dL Reference <=129 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-08-04 | Triglyceride [Mass/volume] in Serum or Plasma | 110 mg/dL Reference <=149 mg/dL |
http://loinc.org · 2571-8 |
| S | 2026-08-04 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5% Reference <=5.6% |
http://loinc.org · 4548-4 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-05-05 | Body height | 170 cm | 8302-2 | S |
| 2026-05-05 | Body weight | 74 kg | 29463-7 | S |
| 2026-05-05 | Body mass index (BMI) [Ratio] | 25.6 kg/m2 | 39156-5 | S |
| 2026-05-05 | Systolic blood pressure | 134 mm[Hg] | 8480-6 | S |
| 2026-05-05 | Diastolic blood pressure | 80 mm[Hg] | 8462-4 | S |
| 2026-05-05 | Heart rate | 70 /min | 8867-4 | S |
| 2026-05-05 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-05-05 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-05-19 | Body height | 170 cm | 8302-2 | S |
| 2026-05-19 | Body weight | 73.8 kg | 29463-7 | S |
| 2026-05-19 | Body mass index (BMI) [Ratio] | 25.5 kg/m2 | 39156-5 | S |
| 2026-05-19 | Systolic blood pressure | 130 mm[Hg] | 8480-6 | S |
| 2026-05-19 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-05-19 | Heart rate | 68 /min | 8867-4 | S |
| 2026-05-19 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-05-19 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-05-19 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-06-16 | Body height | 170 cm | 8302-2 | S |
| 2026-06-16 | Body weight | 73.6 kg | 29463-7 | S |
| 2026-06-16 | Body mass index (BMI) [Ratio] | 25.5 kg/m2 | 39156-5 | S |
| 2026-06-16 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-06-16 | Diastolic blood pressure | 78 mm[Hg] | 8462-4 | S |
| 2026-06-16 | Heart rate | 68 /min | 8867-4 | S |
| 2026-06-16 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-06-16 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-09-15 | Body height | 170 cm | 8302-2 | S |
| 2026-09-15 | Body weight | 73.9 kg | 29463-7 | S |
| 2026-09-15 | Body mass index (BMI) [Ratio] | 25.6 kg/m2 | 39156-5 | S |
| 2026-09-15 | Systolic blood pressure | 128 mm[Hg] | 8480-6 | S |
| 2026-09-15 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-09-15 | Heart rate | 66 /min | 8867-4 | S |
| 2026-09-15 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-09-15 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-09-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-10-27 | Body height | 170 cm | 8302-2 | S |
| 2026-10-27 | Body weight | 74.2 kg | 29463-7 | S |
| 2026-10-27 | Body mass index (BMI) [Ratio] | 25.7 kg/m2 | 39156-5 | S |
| 2026-10-27 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 2026-10-27 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-10-27 | Heart rate | 66 /min | 8867-4 | S |
| 2026-10-27 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-10-27 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-08-04 | Body height | 170 cm | 8302-2 | S |
| 2026-08-04 | Body weight | 73.8 kg | 29463-7 | S |
| 2026-08-04 | Body mass index (BMI) [Ratio] | 25.5 kg/m2 | 39156-5 | S |
| 2026-08-04 | Systolic blood pressure | 126 mm[Hg] | 8480-6 | S |
| 2026-08-04 | Diastolic blood pressure | 76 mm[Hg] | 8462-4 | S |
| 2026-08-04 | Heart rate | 66 /min | 8867-4 | S |
| 2026-08-04 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-08-04 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-08-04 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Retired world champion boxer; later trained other boxers and worked as a corrections officer and a bartender; lives in a house on Long Island with his care partner, who comes to visits with him
- S Asked the routine sexual orientation and gender identity questions, he said he does not like labels for himself; the chart records his preference in his own words and he chose what to share
- S Does not drive; travels by train and bus, usually with his care partner since getting lost once
- S No firearms in the home
- S Never smoked; a beer now and then (AUDIT-C 2); no other drugs
- S Walks most mornings and still shadowboxes at home; eats regular meals
- S Strengths and supports: warmth, humor and generosity, pride in his career and in the fighters he trained, his care partner, family on the islands and in New York, and friends from boxing
Functional status
- S Independent in bathing, dressing, eating and walking; needs reminders for appointments and help with bills (Functional Activities Questionnaire 6, narrative); Timed Up and Go 13 seconds; one fall on ice last winter without injury; standing blood pressure 128/78 mmHg with no drop
Mental status
- S Alert, courteous and warm, with a ready laugh; tells stories in detail but loses the thread and repeats one; tearful when the title fight comes up; mood "down some days"; thought process logical; no hallucinations or delusions; denies thoughts of suicide or of harming anyone; insight good
Structured safety assessment
This assessment is synthetic and does not convert historical behavior into a present-day fact.
Allergies and medications
Allergies
- S No known allergy
Medications
- S Sertraline 25 mg oral tablet, one tablet each morning
- S Sertraline 50 mg oral tablet, one tablet each morning
Procedures and immunizations
Procedures
- S MRI of the brain without contrast, with susceptibility-weighted imaging: mild generalized atrophy, slightly more in the frontal lobes, with hippocampi in the normal range for age (medial temporal atrophy score 1 on each side); a small area of old injury (encephalomalacia with hemosiderin) at the tip of the right frontal lobe; seven microbleeds at the gray-white junction of both frontal lobes; a few small white matter hyperintensities (Fazekas 1); a cavum septi pellucidi; no infarct, mass, subdural collection or hydrocephalus
- S Neuropsychological testing, about three hours with breaks: slowed processing speed and reduced attention, set-shifting and verbal fluency; learning and free recall reduced but much better with cues and recognition (a retrieval pattern rather than rapid forgetting); naming, language and visual perception intact; consistent with mild cognitive impairment of frontal-subcortical type; effort measures valid; mood and PTSD symptoms noted as contributors
- S Cognitive processing therapy for PTSD with the clinic psychologist: twelve weekly sessions, adapted for memory problems (shorter sessions, written one-page summaries, phone reminders, and his care partner helping with practice between sessions, with his consent)
- S Advance care planning conversation, about 30 minutes, with him and his care partner; his capacity to name a health care agent and state his values was assessed and present
- S Physical therapy for balance and strength: ten sessions with a home exercise program (sit-to-stand, heel raises, tandem stance, walking program)
Immunizations
- S 2025-10-14: High-dose influenza vaccine, 2025-2026 season
- S 2026-08-04: Pneumococcal conjugate vaccine PCV20
- S 2026-08-04: Recombinant zoster vaccine, dose 1 of 2
- S 2026-10-27: High-dose influenza vaccine, 2026-2027 season
- S 2026-10-27: Recombinant zoster vaccine, dose 2 of 2
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D 1958 to 1977: Professional boxing from 1958 to 1977, 112 bouts over nineteen years: long exposure to repetitive head impacts; no source read records a count of knockouts or losses of consciousness (CLM-0002, CLM-0003)
- D March 24, 1962: Title fight in 1962 after which his opponent died ten days later; lifelong nightmares and distress about it, in his own public words (CLM-0004, CLM-0005)
- D 1992: Severe beating by a group of men in 1992, one with a baseball bat, with several months in hospital, much of it in intensive care; short-term memory problems reported since (CLM-0008, CLM-0009)
Family history
No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Find the cause of the memory problems and explain it to him in a way he can take in | 2026-06-16 | completed | Mild cognitive impairment most likely due to traumatic brain injury; explained with his care partner present, at his request, with a written summary |
| A clinically meaningful fall in PTSD symptoms (PCL-5 down at least 10 points) by four months | 2026-09-15 | completed | PCL-5 from 41 to 26 after cognitive processing therapy and sertraline |
| Nightmares no more than about once a week, with at least six hours of sleep most nights | 2026-10-27 | completed | Nightmares about once every two weeks; sleeping about six and a half hours |
| No falls, with a balance and strength program | 2026-10-27 | completed | No falls; Timed Up and Go from 13 to 10 seconds after physical therapy and a home program |
| Name a health care agent and record his goals of care while he can take part fully | 2026-08-04 | completed | Health care agent named and goals of care recorded at the annual wellness visit |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Cognitive work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression and PTSD screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a medicine review for anticholinergic and sedating drugs, a sleep apnea screen, hearing and vision checks, and brain MRI | completed | GL-ALZ-2024, GL-ALZ-PC-2024, GL-CMID-2026 |
| Cognitive neurology consultation at the memory clinic to stage the impairment, weigh traumatic brain injury, traumatic encephalopathy syndrome, Alzheimer's disease, vascular disease and the effects of PTSD and depression, and choose further testing | completed | GL-ALZ-2024, GL-TES-2021 |
| PTSD treatment by shared decision: cognitive processing therapy with the clinic psychologist, weekly for about twelve sessions, adapted for memory problems; and sertraline 25 mg each morning, raised to 50 mg after four to six weeks if tolerated, with sodium checked two weeks after starting and after the increase; benzodiazepines avoided | completed | GL-PTSD-2023, GL-BEERS-2023 |
| Collaborative safety plan with warning signs, coping steps, people to call, the clinic number and the 988 Suicide & Crisis Lifeline; medicines kept by his care partner; PHQ-9 item 9 and safety reviewed at every visit | completed | GL-SUICIDE-2024, GL-PTSD-2023 |
| Falls: STEADI assessment, physical therapy for balance and strength with a home program, and a home safety check | completed | GL-STEADI, GL-CMID-2026 |
| Measurement-based care: PCL-5 and PHQ-9 at each chronic-care visit during treatment; MoCA yearly or sooner with change; medicine review every visit | completed | GL-PTSD-2023, GL-CMID-2026, GL-ALZ-2024 |
| After the diagnosis: no cholinesterase inhibitor or memantine, which are not shown to help mild cognitive impairment or traumatic brain injury; memory strategies (one calendar, phone reminders, a fixed daily routine), exercise, social activity, sleep and blood pressure care; repeat neuropsychological testing in twelve to eighteen months or sooner with change; Alzheimer's disease biomarker testing explained and declined for now, as it would not change his care | completed | GL-ALZ-2024, GL-TES-2021, GL-CMID-2026 |
| Travel and money safety: carry a card with his address and his care partner's number, share his phone location, travel with company on unfamiliar routes, and set up shared oversight of bills | completed | GL-ALZ-2024 |
| Caregiver support: education about mild cognitive impairment and PTSD, the Alzheimer's Association 24/7 Helpline (which serves all causes of cognitive impairment), a caregiver class and a burden check; the Medicare GUIDE model explained for if dementia develops later | completed | GL-ALZ-2024, GL-GUIDE |
| Advance care planning while he can take part fully: a health care agent, his values and goals of care, at the annual wellness visit | completed | GL-ALZ-2024, GL-CMID-2026 |
Planned encounters
- 2026-05-05 — Establishing care with his care partner for memory loss and confusion: cognitive testing, reversible causes, PTSD and depression screening with a safety assessment, falls, and the plan (ENC-001)
- 2026-05-19 — Two-week review, seen the same day by cognitive neurology: brain MRI, staging, traumatic encephalopathy syndrome and other causes, sertraline and sodium (ENC-002)
- 2026-06-16 — Six-week review: neuropsychological testing, the diagnosis and the plan, PTSD treatment, safety and caregiver support (ENC-003)
- 2026-08-04 — Subsequent annual wellness visit (ENC-006)
- 2026-09-15 — Four-month review: PTSD after cognitive processing therapy, mood, sodium, falls and caregiver strain (ENC-004)
- 2026-10-27 — Six-month review: PTSD, mood, cognition, safety and the plan for the year ahead (ENC-005)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Annual Wellness Visit, Subsequent
- Progress note 05 — Focused Visit (Follow-up)
- Progress note 06 — Focused Visit (Care-plan review)
- Cognitive Neurology referral
- Cognitive Neurology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Annual Wellness Visit, Subsequent (XML)
- Progress note 05 — Focused Visit (Follow-up) (XML)
- Progress note 06 — Focused Visit (Care-plan review) (XML)
- Cognitive Neurology referral (XML)
- Cognitive Neurology consultation (XML)
Sources
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the PTSD diagnosis at intake in a man with cognitive impairment, sertraline with sodium checks, cognitive processing therapy adapted for memory problems, the handling of traumatic encephalopathy syndrome as a research diagnosis, mild cognitive impairment rather than dementia at this stage, no cholinesterase inhibitor, and Alzheimer's biomarker testing declined. |
| provenance review | not_started | Recent-death rule: only public reports are used (AP, AAP, Salon, NPR, International Business Times, the Scribner Encyclopedia of American Lives and a journalist's obituary feature). The New York Times and Guardian obituaries, Sports Illustrated's 2005 article and the International Boxing Hall of Fame site could not be fetched. The roster's PTSD is recorded as R; its nursing-home and recognition details are not used. |
| safe messaging review | not_started | Mental-health, memory, sexuality and assault claims are marked sensitive. His sexuality is recorded only in his own public words, as social history. The opponent who died is named only in documented history. No relative is named or given a statement, decision or health fact in the modern episode; the care partner is synthetic. The safety assessment is synthetic and asserts no ideation. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.